Why the study?
Genetic variability in anthracycline metabolism could modify the response and safety of acute myeloid leukemia induction.
Do polymorphisms in anthracycline metabolism genes predict response and toxicity in adult de novo AML patients undergoing standard induction chemotherapy?
Do polymorphisms in anthracycline metabolism genes predict response and toxicity in adult de novo AML patients undergoing standard induction chemotherapy?
Genetic variability in anthracycline metabolizing enzymes may be critical in predicting induction toxicities and remission rates in adult patients with de novo AML.
Answers are grounded in this paper and cite their sources.
May support pharmacogenetic stratification in AML induction; leaves open prospective validation before clinical use.
OBJECTIVES: Genetic variability in anthracycline metabolism could modify the response and safety of acute myeloid leukemia (AML) induction. METHODS: Polymorphisms in genes that encodes enzymes of anthracyclines metabolic pathway (CBR3: rs1056892, rs8133052, NQO1: rs1800566, NQO2: rs1143684, NOS3: rs1799983, rs2070744) were evaluated in 225 adult de novo AML patients. RESULTS: The variant CBR3 rs8133052 was associated with lower hepatotoxicity (P = 0.028). Wild-type genotype of NQO2 rs1143684 was related to higher complete remission (P = 0.014), and the variant allele with greater gastrointestinal toxicity (P = 0.024). However, the variant genotype of NQO1 rs1800566 was associated with mucositis (P = 0.018), but heterozygous genotype showed less gastrointestinal toxicity (P = 0.028) and thrombocytopenia (P = 0.009). Protective effects against nephrotoxicity and thrombocytopenia were reported with variant NOS3 rs1799983 (P = 0.006, P = 0.014), whereas carriers of NOS3 rs2070744 showed higher hepatotoxicity and thrombocytopenia (P = 0.017, P = 0.013). CONCLUSIONS: This study supports the influence of genetic variability of idarubicin metabolizing could be critical in predicting anthracycline-induced toxicities.
No takes yet. Share an insight, caveat, or question.
Megías‐Vericat et al. (2021) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: